BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sipponen P, Hyvärinen H. Role of Helicobacter pylori in the Pathogenesis of Gastritis, Peptic Ulcer and Gastric Cancer. Scandinavian Journal of Gastroenterology 2009;28:3-6. [DOI: 10.3109/00365529309098333] [Cited by in Crossref: 139] [Cited by in F6Publishing: 146] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Sreeja SR, Le T, Eom BW, Oh SH, Shivappa N, Hebert JR, Kim MK. Association between the Dietary Inflammatory Index and Gastric Disease Risk: Findings from a Korean Population-Based Cohort Study. Nutrients 2022;14:2662. [DOI: 10.3390/nu14132662] [Reference Citation Analysis]
2 Zhao Y, Cai Y, Chen Z, Li H, Xu Z, Li W, Jia J, Sun Y. SpoT-mediated NapA upregulation promotes oxidative stress-induced Helicobacter pylori biofilm formation and confers multidrug resistance. Antimicrob Agents Chemother 2021:AAC. [PMID: 33649116 DOI: 10.1128/AAC.00152-21] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Lee M, Chung JY, Kim KY, Im W, Kim M. Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model. BMC Microbiol 2020;20:372. [PMID: 33297964 DOI: 10.1186/s12866-020-02055-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Hartl K, Sigal M. Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis. Int J Mol Sci 2020;21:E7439. [PMID: 33050171 DOI: 10.3390/ijms21207439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC; NIKE. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? Rev Endocr Metab Disord 2021;22:511-25. [PMID: 32935263 DOI: 10.1007/s11154-020-09589-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Cai Y, Wang C, Chen Z, Xu Z, Li H, Li W, Sun Y. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter 2020;25:e12715. [PMID: 32548895 DOI: 10.1111/hel.12715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
7 Alfarouk KO, Bashir AHH, Aljarbou AN, Ramadan AM, Muddathir AK, AlHoufie STS, Hifny A, Elhassan GO, Ibrahim ME, Alqahtani SS, AlSharari SD, Supuran CT, Rauch C, Cardone RA, Reshkin SJ, Fais S, Harguindey S. The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management. Front Oncol 2019;9:75. [PMID: 30854333 DOI: 10.3389/fonc.2019.00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
8 Han J, Cui C, Li Y, Gao H, Zhang H, Zhang C, Li Y, Zhou J, Lu C, Su X. Dietary supplement with a mixture of fish oil and krill oil has sex-dependent effects on obese mice gut microbiota. Journal of Functional Foods 2018;51:47-54. [DOI: 10.1016/j.jff.2018.07.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Yu J, Xu Q, Zhang X, Zhu M. Circulating microRNA signatures serve as potential diagnostic biomarkers for Helicobacter pylori infection. J Cell Biochem 2019;120:1735-41. [DOI: 10.1002/jcb.27462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yagura T, Egawa S, Okano A, Mizukoshi K. Chronic Gastritis Due to Helicobacter Pylori Associated with Increased Serum Levels of CA54/61: A Report of Three Cases. Am J Case Rep 2018;19:951-5. [PMID: 30104559 DOI: 10.12659/AJCR.909299] [Reference Citation Analysis]
11 Qu W, Nie C, Zhao J, Ou X, Zhang Y, Yang S, Bai X, Wang Y, Wang J, Li J. Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites. J Agric Food Chem 2018;66:8864-75. [PMID: 30037223 DOI: 10.1021/acs.jafc.8b01466] [Cited by in Crossref: 23] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
12 Assaad S, Chaaban R, Tannous F, Costanian C. Dietary habits and Helicobacter pylori infection: a cross sectional study at a Lebanese hospital. BMC Gastroenterol 2018;18:48. [PMID: 29661143 DOI: 10.1186/s12876-018-0775-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
13 Nishikawa Y, Ikeda Y, Murakami H, Hori SI, Hino K, Sasaki C, Nishikawa M. Classification of atrophic mucosal patterns on Blue LASER Imaging for endoscopic diagnosis of Helicobacter pylori-related gastritis: A retrospective, observational study. PLoS One. 2018;13:e0193197. [PMID: 29596454 DOI: 10.1371/journal.pone.0193197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
14 Suumann J, Sillakivi T, Riispere Ž, Syrjänen K, Sipponen P, Kirsimägi Ü, Peetsalu A. Serological biomarker testing helps avoiding unnecessary endoscopies in obese patients before bariatric surgery. BMC Obes 2018;5:9. [PMID: 29484193 DOI: 10.1186/s40608-018-0185-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations. Helicobacter. 2018;23:e12464. [PMID: 29345408 DOI: 10.1111/hel.12464] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
16 Cui C, Li Y, Gao H, Zhang H, Han J, Zhang D, Li Y, Zhou J, Lu C, Su X. Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice. PLoS One 2017;12:e0186216. [PMID: 29016689 DOI: 10.1371/journal.pone.0186216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
17 Estevam RB, Wood da Silva NMJ, Wood da Silva, Fonseca FM, Oliveira AGD, Nogueira, Pereira SADL, Pereira TL, Adad SJ, Rodrigues VJ, Rodrigues DBR. Modulation of Galectin-3 and Galectin 9 in gastric mucosa of patients with chronic gastritis and positive Helicobacter pylori infection. Pathology - Research and Practice 2017;213:1276-81. [DOI: 10.1016/j.prp.2017.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Abe S, Oda I, Minagawa T, Sekiguchi M, Nonaka S, Suzuki H, Yoshinaga S, Bhatt A, Saito Y. Metachronous Gastric Cancer Following Curative Endoscopic Resection of Early Gastric Cancer. Clin Endosc. 2018;51:253-259. [PMID: 28920420 DOI: 10.5946/ce.2017.104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
19 Takeda S, Igoshi K, Tsend-Ayush C, Oyunsuren T, Sakata R, Koga Y, Arima Y, Takeshita M. Lactobacillus paracasei strain 06TCa19 suppresses inflammatory chemokine induced by Helicobacter pylori in human gastric epithelial cells. Hum Cell 2017;30:258-66. [PMID: 28434172 DOI: 10.1007/s13577-017-0172-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
20 Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Safaralizadeh R. Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran. Microb Pathog. 2017;107:287-292. [PMID: 28390977 DOI: 10.1016/j.micpath.2017.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Rivera-Pérez JI, González AA, Toranzos GA. From Evolutionary Advantage to Disease Agents: Forensic Reevaluation of Host-Microbe Interactions and Pathogenicity. Microbiol Spectr 2017;5. [PMID: 28155809 DOI: 10.1128/microbiolspec.EMF-0009-2016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Cho EJ, Um SI, Han JH, Kim B, Han SB, Jeong JH, Kim HR, Kim I, Whang WK, Lee E, Sohn UD. The cytoprotective effect of Rumex Aquaticus Herba extract against hydrogen peroxide-induced oxidative stress in AGS cells. Arch Pharm Res 2016;39:1739-47. [DOI: 10.1007/s12272-016-0863-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
23 Abadi AT, Kusters JG. Management of Helicobacter pylori infections. BMC Gastroenterol. 2016;16:94. [PMID: 27520775 DOI: 10.1186/s12876-016-0496-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
24 Briskey D, Tucker PS, Johnson DW, Coombes JS. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Nitric Oxide 2016;57:64-70. [DOI: 10.1016/j.niox.2016.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
25 Kawanaka M, Watari J, Kamiya N, Yamasaki T, Kondo T, Toyoshima F, Ikehara H, Tomita T, Oshima T, Fukui H, Daimon T, Das KM, Miwa H. Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer. 2016;114:21-29. [PMID: 26671747 DOI: 10.1038/bjc.2015.418] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
26 Yu M, Zhang XY, Yu Q. Detection of oral Helicobacter Pylori infection using saliva test cassette. Pak J Med Sci 2015;31:1192-6. [PMID: 26649012 DOI: 10.12669/pjms.315.7626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Marwaha S, Schumacher MA, Zavros Y, Eghbalnia HR. Crosstalks between cytokines and Sonic Hedgehog in Helicobacter pylori infection: a mathematical model. PLoS One 2014;9:e111338. [PMID: 25364910 DOI: 10.1371/journal.pone.0111338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, Olin-Sandoval V, Grüning NM, Krüger A, Tauqeer Alam M, Keller MA, Breitenbach M, Brindle KM, Rabinowitz JD, Ralser M. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc 2015;90:927-63. [PMID: 25243985 DOI: 10.1111/brv.12140] [Cited by in Crossref: 438] [Cited by in F6Publishing: 524] [Article Influence: 54.8] [Reference Citation Analysis]
29 Choo SW, Ang MY, Fouladi H, Tan SY, Siow CC, Mutha NV, Heydari H, Wee WY, Vadivelu J, Loke MF, Rehvathy V, Wong GJ. HelicoBase: a Helicobacter genomic resource and analysis platform. BMC Genomics 2014;15:600. [PMID: 25030426 DOI: 10.1186/1471-2164-15-600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
30 Michaeli M, Tabibian-Keissar H, Schiby G, Shahaf G, Pickman Y, Hazanov L, Rosenblatt K, Dunn-Walters DK, Barshack I, Mehr R. Immunoglobulin gene repertoire diversification and selection in the stomach - from gastritis to gastric lymphomas. Front Immunol 2014;5:264. [PMID: 24917868 DOI: 10.3389/fimmu.2014.00264] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
31 Lee SE, Lim JW, Kim JM, Kim H. Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori-infected gastric epithelial cells. Mediators Inflamm 2014;2014:128919. [PMID: 24987192 DOI: 10.1155/2014/128919] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
32 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 128] [Cited by in F6Publishing: 113] [Article Influence: 16.0] [Reference Citation Analysis]
33 Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: Current status and future concepts. World J Gastroenterol 2014; 20(18): 5283-5293 [PMID: 24833858 DOI: 10.3748/wjg.v20.i18.5283] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 80] [Article Influence: 11.6] [Reference Citation Analysis]
34 Settin A, Abdalla AF, Al-hussaini AS, El-baz R, Galal A. Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. Indian J Gastroenterol 2014;33:330-5. [DOI: 10.1007/s12664-014-0450-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
35 Bae SE, Jung HY, Kang J, Park YS, Baek S, Jung JH, Choi JY, Kim MY, Ahn JY, Choi KS, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol 2014;109:60-7. [PMID: 24343545 DOI: 10.1038/ajg.2013.404] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 9.3] [Reference Citation Analysis]
36 Ito Y, Vela JL, Matsumura F, Hoshino H, Tyznik A, Lee H, Girardi E, Zajonc DM, Liddington R, Kobayashi M, Bao X, Bugaytsova J, Borén T, Jin R, Zong Y, Seeberger PH, Nakayama J, Kronenberg M, Fukuda M. Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 2013;8:e78191. [PMID: 24312443 DOI: 10.1371/journal.pone.0078191] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
37 Brenciaglia M, Fornara A, Scaltrito M, Braga P. Inhibitory and Bactericidal Activity of Rokitamycin against Helicobacter pylori and Morphological Alterations. Journal of Chemotherapy 2013;8:425-31. [DOI: 10.1179/joc.1996.8.6.425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Tonkić M, Tonkić A, Goić-barišić I, Šcimunić M, Punda-polić V; Jukić. Primary Resistance and Antibiotic Minimum Inhibitory Concentrations for Helicobacter pylori Strains in Split, Croatia. Journal of Chemotherapy 2013;18:437-9. [DOI: 10.1179/joc.2006.18.4.437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Rolig AS, Shanks J, Carter JE, Ottemann KM. Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum. Infect Immun 2012;80:3713-20. [PMID: 22802346 DOI: 10.1128/IAI.00407-12] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
40 Karasawa F, Shiota A, Goso Y, Kobayashi M, Sato Y, Masumoto J, Fujiwara M, Yokosawa S, Muraki T, Miyagawa S. Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest. 2012;122:923-934. [PMID: 22307328 DOI: 10.1172/jci59087] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
41 Meine GC, Rota C, Dietz J, Sekine S, Prolla JC. Relationship between cagA-positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil. Arq Gastroenterol 2011;48:41-5. [PMID: 21537541 DOI: 10.1590/s0004-28032011000100009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
42 Chu G, Qi S, Yang G, Dou K, Du J, Lu Z. Gastrointestinal tract specific gene GDDR inhibits the progression of gastric cancer in a TFF1 dependent manner. Mol Cell Biochem 2012;359:369-74. [DOI: 10.1007/s11010-011-1030-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
43 Watari J, Moriichi K, Tanabe H, Kashima S, Nomura Y, Fujiya M, Tomita T, Oshima T, Fukui H, Miwa H. Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication. Int J Cancer. 2012;130:2349-2358. [PMID: 21732341 DOI: 10.1002/ijc.26275] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
44 Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, Yoon DH, Lim SH, Kim YS, Yim JY, Kim JS, Jung HC. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver 2011;5:321-7. [PMID: 21927661 DOI: 10.5009/gnl.2011.5.3.321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
45 Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, Yoon DH, Lim SH, Kim YS, Yim JY. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver. 2011;5:321-327. [PMID: 21927661 DOI: 10.5009/qnl.2011.5.3.321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Wang L, Zhang XY, Xu L, Liu WJ, Zhang J, Zhang JP. Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncol Lett 2011;2:707-12. [PMID: 22848253 DOI: 10.3892/ol.2011.292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
47 Woodward KN. Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review. ISRN Vet Sci 2011;2011:210982. [PMID: 23738095 DOI: 10.5402/2011/210982] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
48 Redéen S, Petersson F, Kechagias S, Mårdh E, Borch K. Natural history of chronic gastritis in a population-based cohort. Scand J Gastroenterol 2010;45:540-9. [PMID: 20180646 DOI: 10.3109/00365521003624151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
49 Brenciaglia MI, Fornara AM, Scaltrito MM, Dubini F. 'In vitro' development of metronidazole, erythromycin, amoxicillin and gentamicin resistance in Helicobacter pylori. Int J Antimicrob Agents 1996;6:223-6. [PMID: 18611711 DOI: 10.1016/0924-8579(95)00040-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Liu TW, Ho CW, Huang HH, Chang SM, Popat SD, Wang YT, Wu MS, Chen YJ, Lin CH. Role for alpha-L-fucosidase in the control of Helicobacter pylori-infected gastric cancer cells. Proc Natl Acad Sci U S A. 2009;106:14581-14586. [PMID: 19666478 DOI: 10.1073/pnas.0903286106] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
51 Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus. 2009;22:256-263. [PMID: 19425207 DOI: 10.1111/j.1442-2050.2008.00911.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
52 Kobayashi M, Fukuda M, Nakayama J. Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases. Biol Pharm Bull 2009;32:774-9. [PMID: 19420741 DOI: 10.1248/bpb.32.774] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
53 Slomiany BL, Piotrowski J, Majka J, Slomiany A. Sucralfate Affects the Susceptibility of Helicobacter pylori to Antimicrobial Agents. Scandinavian Journal of Gastroenterology 2009;30:82-4. [DOI: 10.3109/00365529509090278] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
54 Olbe L. Strong activation of PAR-2 receptors: A common trigger for the development of gastrointestinal adenocarcinomas? Scandinavian Journal of Gastroenterology 2009;42:1133-7. [DOI: 10.1080/00365520601175983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
55 Slomiany A, Piotrowski J, Slomiany BL. Sucralfate Counteracts the Inhibition of Gastric Mucosal Mucin Receptor by Helicobacter pylori Lipopolysaccharide. Scandinavian Journal of Gastroenterology 2009;30:77-81. [DOI: 10.3109/00365529509090277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
56 Kobayashi M, Lee H, Nakayama J, Fukuda M. Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection. Curr Drug Metab. 2009;10:29-40. [PMID: 19149511 DOI: 10.2174/138920009787048428] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
57 Kobayashi M, Lee H, Nakayama J, Fukuda M. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology. 2009;19:453-461. [PMID: 19150806 DOI: 10.1093/glycob/cwp004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
58 Benoit BN, Kobayashi M, Kawakubo M, Takeoka M, Sano K, Zou J, Itano N, Tsutsui H, Noda T, Fukuda M, Nakayama J, Taniguchi S. Role of ASC in the mouse model of Helicobacter pylori infection. J Histochem Cytochem 2009;57:327-38. [PMID: 19064716 DOI: 10.1369/jhc.2008.952366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
59 Tang RX, Luo DJ, Sun AH, Yan J. Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies. World J Gastroenterol 2008; 14(30): 4816-4822 [PMID: 18720546 DOI: 10.3748/wjg.14.4816] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
60 Akyildiz M, Akay S, Musoglu A, Tuncyurek M, Aydin A. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication. Eur J Intern Med. 2009;20:53-57. [PMID: 19237093 DOI: 10.1016/j.ejim.2008.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sezgin O, Altintaş E, Nayir E, Uçbilek E. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. Helicobacter 2007;12:629-32. [PMID: 18001405 DOI: 10.1111/j.1523-5378.2007.00547.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
62 Xie XF, Ito M, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori-associated gastritis is related to babA2 expression without heterogeneity of the 3' region of the cagA genotype in gastric biopsy specimens. Pathobiology 2007;74:309-16. [PMID: 17890898 DOI: 10.1159/000105814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
63 Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, Lee HS, Choe C, Lee DH, Jung HC. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol. 2007;41:751-755. [PMID: 17700423 DOI: 10.1097/mcg.0b013e31802c347d] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
64 Mirzaei J, Siavoshi F, Emami S, Safari F, Khoshayand MR, Shafiee A, Foroumadi A. Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds. Eur J Med Chem. 2008;43:1575-1580. [PMID: 18192086 DOI: 10.1016/j.ejmech.2007.11.019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
65 Leib MS, Duncan RB, Ward DL. Triple Antimicrobial Therapy and Acid Suppression in Dogs with Chronic Vomiting and Gastric Helicobacter spp. Journal of Veterinary Internal Medicine 2007;21:1185-92. [DOI: 10.1111/j.1939-1676.2007.tb01936.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
66 Sezgin O, Altıntaş E, Üçbilek E, Tombak A, Tellio?lu B. Low Efficacy Rate of Moxifloxacin-Containing Helicobacter pylori Eradication Treatment: In an Observational Study in a Turkish Population. Helicobacter 2007;12:518-22. [DOI: 10.1111/j.1523-5378.2007.00535.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
67 Tashiro J, Miwa J, Tomita T, Matsubara Y, Oota Y. GASTRIC CANCER DETECTED AFTER HELICOBACTER PYLORI ERADICATION. Dig Endosc 2007;19:167-73. [DOI: 10.1111/j.1443-1661.2007.00749.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
68 Muller LB, Fagundes RB, Moraes CCD, Rampazzo A. Prevalência da infecção por Helicobacter pylori e das lesões precusoras do câncer gástrico em pacientes dispéticos. Arq Gastroenterol 2007;44:93-8. [DOI: 10.1590/s0004-28032007000200002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
69 Tanaka A, Watari J, Tanabe H, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia: GENETIC INSTABILITIES IN INTESTINAL METAPLASIA. Alimentary Pharmacology & Therapeutics 2006;24:194-202. [DOI: 10.1111/j.1365-2036.2006.00045.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Kamoda O, Anzai K, Mizoguchi J, Shiojiri M, Yanagi T, Nishino T, Kamiya S. In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection. Antimicrob Agents Chemother 2006;50:3062-9. [PMID: 16940102 DOI: 10.1128/AAC.00036-06] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
71 Kobayashi M, Lee H, Schaffer L, Gilmartin TJ, Head SR, Takaishi S, Wang TC, Nakayama J, Fukuda M. A distinctive set of genes is upregulated during the inflammation-carcinoma sequence in mouse stomach infected by Helicobacter felis. J Histochem Cytochem 2007;55:263-74. [PMID: 17101721 DOI: 10.1369/jhc.6A7097.2006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
72 Kang HY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci. 2006;51:2310-2315. [PMID: 17080249 DOI: 10.1007/s10620-006-9276-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
73 Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agréus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006;11:224-230. [PMID: 16882324 DOI: 10.1111/j.1523-5378.2006.00414.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
74 Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, Okamoto K, Maemoto A, Fujiya M, Ashida T. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer. J Clin Pathol. 2007;60:921-926. [PMID: 16997920 DOI: 10.1136/jcp.2006.041939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
75 Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD. H pylori infection among 1000 southern Iranian dyspeptic patients. World J Gastroenterol 2006; 12(34): 5479-5482 [PMID: 17006984 DOI: 10.3748/wjg.v12.i34.5479] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
76 Lam VWT, Trinh LK, Wilson RB. HELICOBACTER PYLORI INFECTION AND TREATMENT OUTCOME IN AN URBAN AUSTRALIAN POPULATION. ANZ J Surg 2006;76:710-4. [DOI: 10.1111/j.1445-2197.2006.03836.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
77 Tanaka A, Watari J, Tanabe H, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther Symp Series 2006;2:194-202. [DOI: 10.1111/j.1746-6342.2006.00045.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Lehmann FS, Beglinger C. Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. Expert Opin Pharmacother. 2005;6:93-104. [PMID: 15709887 DOI: 10.1517/14656566.6.1.93] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006;55:158-64. [PMID: 16120761 DOI: 10.1136/gut.2005.072942] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
80 Gurbuz AK, Ozel AM, Narin Y, Yazgan Y, Baloglu H, Demirturk L. Is the remarkable contradiction between histology and 14C urea breath test in the detection of Helicobacter pylori due to false-negative histology or false-positive 14C urea breath test? J Int Med Res. 2005;33:632-640. [PMID: 16372580 DOI: 10.1177/147323000503300604] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
81 Chimenti F, Bizzarri B, Bolasco A, Secci D, Chimenti P, Carradori S, Granese A, Rivanera D, Lilli D, Scaltrito MM, Brenciaglia MI. Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Eur J Med Chem 2006;41:208-12. [PMID: 16377035 DOI: 10.1016/j.ejmech.2005.11.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
82 Matthews GM, Butler RN. Cellular mucosal defense during Helicobacter pylori infection: a review of the role of glutathione and the oxidative pentose pathway. Helicobacter. 2005;10:298-306. [PMID: 16104945 DOI: 10.1111/j.1523-5378.2005.00327.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
83 Yamada M, Wong F, Fujiwara S, Tatsukawa Y, Suzuki G. Smoking and Alcohol Habits as Risk Factors for Benign Digestive Diseases in a Japanese Population: The Radiation Effects Research Foundation Adult Health Study. Digestion 2005;71:231-7. [DOI: 10.1159/000087048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
84 Calvet X. [Helicobacter pylori eradication treatment in non-ulcerous disease]. Gastroenterol Hepatol. 2005;28:40-46. [PMID: 15691468 DOI: 10.1157/13070383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
85 Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, Takamatsu J, Adachi K, El-Omar E, Ohta M. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter. 2004;9:443-452. [PMID: 15361084 DOI: 10.1111/j.1083-4389.2004.00261.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
86 Karita M, Teramukai S, Matsumoto S, Shibuta H. Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces progressive atrophic gastritis that is associated with the development of gastric cancer. Dig Dis Sci. 2005;50:56-64. [PMID: 15712638 DOI: 10.1007/s10620-005-1278-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
87 Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, Granese A, Rivanera D, Lilli D, Scaltrito M, Brenciaglia M. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Bioorganic & Medicinal Chemistry Letters 2005;15:603-7. [DOI: 10.1016/j.bmcl.2004.11.042] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
88 Karita M, Noriyasu A, Teramukai S, Matsumoto S. Atrophic progression induced by H. pylori infection is correlated with a changing pepsinogen I value and associated with the development of gastric cancer. Dig Dis Sci 2004;49:1615-20. [PMID: 15573915 DOI: 10.1023/b:ddas.0000043374.80528.ee] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
89 Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, Fukuda M. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci U S A 2004;101:17807-12. [PMID: 15591109 DOI: 10.1073/pnas.0407503101] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.7] [Reference Citation Analysis]
90 Huhtinen HT, Grönroos JM, Uksila J, Grass DS, Nevalainen TJ, Laine VJO. Experimental Helicobacter felis Infection in Transgenic Mice Expressing Human Group IIA Phospholipase A2. Helicobacter 2004;9:408-16. [DOI: 10.1111/j.1083-4389.2004.00257.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
91 Mizuki A, Tatemichi M, Nishiya H, Fukui K, Hayashi T, Tsukada N, Nagata H, Ishii H. Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers. J Gastroenterol Hepatol. 2004;19:528-534. [PMID: 15086596 DOI: 10.1111/j.1440-1746.2004.03359.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
92 Ueda M, Kikuchi S, Kasugai T, Shunichi T, Miyake C. Helicobacter pylori risk associated with childhood home environment. Cancer Sci 2003;94:914-8. [PMID: 14556666 DOI: 10.1111/j.1349-7006.2003.tb01375.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
93 Tatemichi M, Ogura T, Sakurazawa N, Nagata H, Sugita M, Esumi H. Inducible nitric oxide synthase activity induced by sodium chloride solution prolongs luminal pH elevation in rat and mouse stomachs. J Gastroenterol Hepatol 2003;18:1039-46. [PMID: 12911660 DOI: 10.1046/j.1440-1746.2003.03130.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
94 Wen Y, Marcus EA, Matrubutham U, Gleeson MA, Scott DR, Sachs G. Acid-adaptive genes of Helicobacter pylori. Infect Immun. 2003;71:5921-5939. [PMID: 14500513 DOI: 10.1128/iai.71.10.5921-5939.2003] [Cited by in Crossref: 163] [Cited by in F6Publishing: 155] [Article Influence: 8.6] [Reference Citation Analysis]
95 Mckenna D, Watson P, Dornan J. Helicobacter pylori Infection and Dyspepsia in Pregnancy: . Obstetrics & Gynecology 2003;102:845-9. [DOI: 10.1097/00006250-200310000-00029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
96 Oztürk E, Yeşilova Z, Ilgan S, Arslan N, Erdil A, Celasun B, Ozgüven M, Dağalp K, Ovali O, Bayhan H. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging 2003;30:1457-62. [PMID: 14579083 DOI: 10.1007/s00259-003-1244-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
97 Bulent K, Murat A, Esin A, Fatih K, MMMurat H, Hakan H, Melih K, Mehmet A, Bulent Y, Fatih H. Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol 2003; 9(7): 1580-1583 [PMID: 12854168 DOI: 10.3748/wjg.v9.i7.1580] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
98 Sun YQ, Monstein HJ, Nilsson LE, Petersson F, Borch K. Profiling and identification of eubacteria in the stomach of Mongolian gerbils with and without Helicobacter pylori infection. Helicobacter. 2003;8:149-157. [PMID: 12662383 DOI: 10.1046/j.1523-5378.2003.00136.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
99 Kawabata H, Habu Y, Tomioka H, Kutsumi H, Kobayashi M, Oyasu K, Hayakumo T, Mizuno S, Kiyota K, Nakajima M. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Aliment Pharmacol Ther. 2003;17:259-264. [PMID: 12534411 DOI: 10.1046/j.1365-2036.2003.01406.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
100 Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002;13:376. [PMID: 12225782 DOI: 10.1016/s0953-6205(02)00094-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
101 Petersson F, Borch K, Franzén LE. Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection. Dig Dis Sci 2002;47:1558-66. [PMID: 12141817 DOI: 10.1023/a:1015938303993] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
102 Kitabatake M, Ali K, Demain A, Sakamoto K, Yokoyama S, Söll D. Indolmycin resistance of Streptomyces coelicolor A3(2) by induced expression of one of its two tryptophanyl-tRNA synthetases. J Biol Chem 2002;277:23882-7. [PMID: 11970956 DOI: 10.1074/jbc.M202639200] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.1] [Reference Citation Analysis]
103 Al-Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up. Br J Clin Pharmacol. 2002;53:163-171. [PMID: 11851640 DOI: 10.1046/j.0306-5251.2001.01531.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 2.8] [Reference Citation Analysis]
104 Beales IL. Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol. 2002;2:7. [PMID: 11936957 DOI: 10.1186/1471-230x-2-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
105 Gosciniak G, Glupczynski Y, Goutier S, Van Den Borre C, Butzler JP, Przondo-Mordarska A. Prevalence of antibiotic resistance in Helicobacter pylori strains in Poland. Clin Microbiol Infect 1998;4:726-8. [PMID: 11864282 DOI: 10.1111/j.1469-0691.1998.tb00659.x] [Reference Citation Analysis]
106 Lo C, Hsu P, Lo G, Lai K, Cheng J, Tseng H, Lin C, Chan H, Wang Y, Ku M, Lin C, Peng N, Chien EJ. Comparison of clinical, serological and histological findings between non‐ulcer dyspepsia patients with and without Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2001;16:276-81. [DOI: 10.1046/j.1440-1746.2001.02417.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
107 Kanamaru T, Nakano Y, Toyoda Y, Miyagawa KI, Tada M, Kaisho T, Nakao M. In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection. Antimicrob Agents Chemother. 2001;45:2455-2459. [PMID: 11502514 DOI: 10.1128/aac.45.9.2455-2459.2001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
108 Koskenpato J, Farkkilä M, Sipponen P. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol 2001;96:2866-72. [PMID: 11693319 DOI: 10.1111/j.1572-0241.2001.04240.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
109 Eksteen JA, Scott PA, Perry I, Jankowski JA. Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev 2001;10:163-6. [PMID: 11330458 DOI: 10.1097/00008469-200104000-00008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
110 Suto H, Azuma T, Ito S, Ohtani M, Dojo M, Ito Y, Kohli Y, Kuriyama M. Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis. Gut 2001;48:605-8. [PMID: 11302955 DOI: 10.1136/gut.48.5.605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
111 Sachs G, Shin JM, Munson K, Vagin O, Lambrecht N, Scott DR, Weeks DL, Melchers K. Review article: the control of gastric acid and Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000;14:1383-1401. [PMID: 11069309 DOI: 10.1046/j.1365-2036.2000.00837.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
112 Thoreson AC, Hamlet A, Celik J, Byström M, Nyström S, Olbe L, Svennerholm AM. Differences in surface-exposed antigen expression between Helicobacter pylori strains isolated from duodenal ulcer patients and from asymptomatic subjects. J Clin Microbiol 2000;38:3436-41. [PMID: 10970397 DOI: 10.1128/JCM.38.9.3436-3441.2000] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
113 Koskenpato J, Korppi-Tommola T, Kairemo K, Färkkilä M. Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia. Dig Dis Sci. 2000;45:1763-1768. [PMID: 11052317 DOI: 10.1023/a:1005582211673] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
114 Ormsby AH, Kilgore SP, Goldblum JR, Richter JE, Rice TW, Gramlich TL. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol. 2000;13:614-620. [PMID: 10874664 DOI: 10.1038/modpathol.3880106] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
115 Borch K, Jönsson KA, Petersson F, Redéen S, Mårdh S, Franzén LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci 2000;45:1322-9. [PMID: 10961710 DOI: 10.1023/a:1005547802121] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 2.4] [Reference Citation Analysis]
116 Danielsson D, Farmery SM, Blomberg B, Perry S, Rautelin H, Crabtree JE. Co-expression in Helicobacter pylori of cagA and non-opsonic neutrophil activation enhances the association with peptic ulcer disease. J Clin Pathol 2000;53:318-21. [PMID: 10823130 DOI: 10.1136/jcp.53.4.318] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
117 Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, Kohli Y, Kuriyama M. Endoscopic [13C]-urea breath test for quantification of Helicobacter pylori infection. J Gastroenterol Hepatol. 2000;15:161-167. [PMID: 10735540 DOI: 10.1046/j.1440-1746.2000.02067.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
118 Bergquist C, Mattsson-rydberg A, Lönroth H, Svennerholm A. Development of a new method for the determination of immune responses in the human stomach. Journal of Immunological Methods 2000;234:51-9. [DOI: 10.1016/s0022-1759(99)00213-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
119 Ofman JJ, Etchason J, Alexander W, Stevens BR, Herrin J, Cangialose C, Ballard DJ, Bratzler D, Elward KS, FitzGerald D, Culpepper-Morgan J, Marshall B. The quality of care for Medicare patients with peptic ulcer disease. Am J Gastroenterol 2000;95:106-13. [PMID: 10638567 DOI: 10.1111/j.1572-0241.2000.01514.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
120 Matsushima Y, Aoyama N, Fukuda H, Kinoshita Y, Todo A, Himeno S, Fujimoto S, Kasuga M, Nakase H, Chiba T. Gastric ulcer formation after the Hanshin-Awaji earthquake: a case study of Helicobacter pylori infection and stress-induced gastric ulcers. Helicobacter. 1999;4:94-99. [PMID: 10382122 DOI: 10.1046/j.1523-5378.1999.98290.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
121 Vos M, Warren RM, van Rensburg CJ, Hauman JH, Epplen JT, van Helden PD. Rapid genomic diversification ofHelicobacter pylori. Electrophoresis 1999;20:1476-85. [DOI: 10.1002/(sici)1522-2683(19990601)20:7<1476::aid-elps1476>3.0.co;2-b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
122 Atuma C, Engstrand L, Holm L. Extracts of Helicobacter pylori reduce gastric mucosal blood flow through a VacA- and CagA-independent pathway in rats. Scand J Gastroenterol 1998;33:1256-61. [PMID: 9930388 DOI: 10.1080/00365529850172331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
123 Safatle-Ribeiro AV, Ribeiro U Jr, Clarke MR, Sakai P, Ishioka S, Garrido AB Jr, Gama- Rodrigues J, Safatle NF, Reynolds JC. Relationship between persistence of Helicobacter pylori and dysplasia, intestinal, metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci. 1999;44:243-252. [PMID: 10063907 DOI: 10.1023/A:1026681829083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
124 Hamlet A, Thoreson AC, Nilsson O, Svennerholm AM, Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 1999;116:259-268. [PMID: 9922305 DOI: 10.1016/s0016-5085(99)70121-6] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 4.4] [Reference Citation Analysis]
125 Hua J, Ho B, Zheng P, Yeoh KG, Ng HC, Lim SG. Coexistence of Helicobacter pylori spiral and coccoid forms in experimental mice. World J Gastroenterol 1998; 4(6): 485-488 [PMID: 11819350 DOI: 10.3748/wjg.v4.i6.485] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun 1998;66:5477-84. [PMID: 9784560 DOI: 10.1128/IAI.66.11.5477-5484.1998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 2.7] [Reference Citation Analysis]
127 de Figueiredo Soares T, de Magalhães Queiroz DM, Mendes EN, Rocha GA, Oliveira AMR, Álvares Cabral MMD, de Oliveira CA. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. American Journal of Gastroenterology 1998;93:1841-7. [DOI: 10.1111/j.1572-0241.1998.533_d.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
128 el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-33. [PMID: 9863476 DOI: 10.1136/gut.43.3.327] [Cited by in Crossref: 251] [Cited by in F6Publishing: 232] [Article Influence: 10.5] [Reference Citation Analysis]
129 Mattsson A, Tinnert A, Hamlet A, Lönroth H, Bölin I, Svennerholm AM. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol 1998;5:288-93. [PMID: 9605978 DOI: 10.1128/CDLI.5.3.288-293.1998] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 2.9] [Reference Citation Analysis]
130 Cutler AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. The American Journal of Medicine 1998;105:18-20. [DOI: 10.1016/s0002-9343(98)00134-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
131 Mattsson A, Quiding-Järbrink M, Lönroth H, Hamlet A, Ahlstedt I, Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 1998;66:2705-12. [PMID: 9596737 DOI: 10.1128/IAI.66.6.2705-2712.1998] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
132 Mattsson A, Quiding-Järbrink M, Lönroth H, Hamlet A, Ahlstedt I, Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 1998;66:2705-12. [PMID: 9596737 DOI: 10.1128/IAI.66.6.2705-2712.1998] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 2.8] [Reference Citation Analysis]
133 Borch K, Sjostedt C, Hannestad U, Soderholm JD, Franzen L, Mardh S. . Digestive Diseases and Sciences;43:749-53. [DOI: 10.1023/a:1018809913230] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
134 Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998;114:633-639. [PMID: 9516382 DOI: 10.1016/s0016-5085(98)70576-1] [Cited by in Crossref: 188] [Cited by in F6Publishing: 185] [Article Influence: 7.8] [Reference Citation Analysis]
135 Cao J, Li ZQ, Borch K, Petersson F, Mårdh S. Detection of spiral and coccoid forms of Helicobacter pylori using a murine monoclonal antibody. Clin Chim Acta 1997;267:183-96. [PMID: 9469252 DOI: 10.1016/s0009-8981(97)00134-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
136 Kim HY, Kim YB, Park CK, Yoo JY, Graham DY. Co-existing gastric cancer and duodenal ulcer disease: role of Helicobacter pylori infection. Helicobacter. 1997;2:205-209. [PMID: 9421125 DOI: 10.1111/j.1523-5378.1997.tb00089.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
137 Lindholm C, Osek J, Svennerholm AM. Quantification of conserved antigens in Helicobacter pylori during different culture conditions. Infect Immun 1997;65:5376-80. [PMID: 9393845 DOI: 10.1128/iai.65.12.5376-5380.1997] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
138 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181. [PMID: 8827022 DOI: 10.1097/00000478-199610000-00001] [Cited by in Crossref: 2889] [Cited by in F6Publishing: 3154] [Article Influence: 111.1] [Reference Citation Analysis]
139 Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996;20 Suppl 1:S23-30. [PMID: 8694146 DOI: 10.1097/00000478-199600001-00004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 2.2] [Reference Citation Analysis]
140 Hamlet AK, Erlandsson KI, Olbe L, Svennerholm AM, Backman VE, Pettersson AB. A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1995;30:1058-63. [PMID: 8578164 DOI: 10.3109/00365529509101607] [Cited by in Crossref: 46] [Cited by in F6Publishing: 58] [Article Influence: 1.8] [Reference Citation Analysis]
141 Slomiany BL, Piotrowski J, Murty VL, Slomiany A. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine. Gen Pharmacol 1995;26:1553-8. [PMID: 8690245 DOI: 10.1016/0306-3623(95)00048-8] [Reference Citation Analysis]
142 Krakowka S, Eaton KA, Rings DM. Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect Immun 1995;63:2352-5. [DOI: 10.1128/iai.63.6.2352-2355.1995] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
143 Wyatt JI. Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori. Histopathology. 1995;26:1-15. [PMID: 7713479 DOI: 10.1111/j.1365-2559.1995.tb00614.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
144 Genta RM, Graham DY. Helicobacter pylori: the new bug on the (paraffin) block. Virchows Arch. 1994;425:339-347. [PMID: 7820298 DOI: 10.1007/bf00189571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
145 Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994;48:91-132. [PMID: 7525198 DOI: 10.2165/00003495-199448010-00008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 2.6] [Reference Citation Analysis]
146 Goldman RC, Zakula D, Flamm R, Beyer J, Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994;38:1496-500. [PMID: 7979278 DOI: 10.1128/AAC.38.7.1496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]